Candy V6 Vaginal Tablets are a triple-action formulation designed to treat bacterial, fungal, and protozoal vaginal infections while supporting the restoration of normal vaginal flora. The combination of Metronidazole, Clotrimazole, and Lactic Acid Bacillus provides comprehensive management of common gynecological infections.
Metronidazole is effective against anaerobic bacteria and protozoa, Clotrimazole targets fungal infections such as Candida, and Lactic Acid Bacillus helps restore and maintain the natural vaginal environment by replenishing beneficial bacteria.
Candy V6 is commonly prescribed for conditions such as bacterial vaginosis, mixed vaginal infections, candidiasis, and abnormal vaginal discharge. The tablets are intended for vaginal use only and should be used strictly as directed by a healthcare professional.
Key Benefits
-
Treats mixed vaginal infections
-
Antibacterial, antifungal, and probiotic action
-
Helps restore healthy vaginal flora
-
Reduces itching, discharge, and irritation
-
Convenient vaginal tablet formulation
Composition
Each vaginal tablet contains:
-
Metronidazole – 500 mg
-
Clotrimazole – 100 mg
-
Lactic Acid Bacillus – 150 million spores
Indications
-
Bacterial vaginosis
-
Vaginal candidiasis
-
Trichomoniasis (as prescribed)
-
Mixed vaginal infections
Dosage & Administration
Use as prescribed by a qualified healthcare professional. Tablets are for vaginal use only, usually administered once daily at bedtime for the recommended duration.
Pack Size
-
6 vaginal tablets
Storage Instructions
-
Store below 25°C
-
Protect from moisture and direct sunlight
-
Keep out of reach of children
Important Notice
-
Prescription-only medicine
-
Not for oral use
-
Avoid use during menstruation unless advised
-
Complete the full course as prescribed
Product Category (WooCommerce)
Pharmaceuticals → Gynecological Products → Vaginal Anti-infectives
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
ACLOX (Chlorzoxazone 500 mg + Paracetamol 250 mg)
ACLOX MR (Aceclofenac 100 mg + Paracetamol 375 mg + Chlorzoxazone 500 mg)
ACLOX MR is a powerful triple-action medication designed for the management of severe musculoskeletal pain associated with muscle spasms. This advanced formula combines three active ingredients: 100 mg of Aceclofenac (a strong anti-inflammatory), 375 mg of Paracetamol (an analgesic), and 500 mg of Chlorzoxazone (a muscle relaxant). This combination effectively targets pain, inflammation, and muscle stiffness simultaneously. It is a Prescription Only Medicine (POM) supplied in a box of 20 tablets (2 strips of 10). It is ideal for acute conditions where standard painkillers are insufficient.
AMOCLACID 228.5mg/5ml Powder for Oral Suspension (70 ml)
AMOCLACID 228.5mg/5ml is a broad-spectrum antibiotic formulation designed primarily for pediatric use. It comes as a dry powder that acts as a suspension when reconstituted with water. Each 5ml of the prepared syrup contains 200 mg of Amoxicillin and 28.5 mg of Clavulanic Acid. This "Twice daily dosing" formula is highly effective against bacterial infections that may be resistant to amoxicillin alone. The product is a Prescription Only Medicine (POM) supplied in a 70 ml bottle and features a flavoured syrupy base to ensure easier administration for children.
Reviews
There are no reviews yet.